
51 - 200 employees
🏥 Healthcare
💊 Pharmaceuticals
🧬 Biotechnology
💰 $123.2M Post-IPO Equity - Melinta Therapeutics on 2018-05
Healthcare • Pharmaceuticals • Biotechnology
Melinta Therapeutics is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for acute and life-threatening illnesses, with a particular emphasis on infectious diseases. The company maintains a portfolio of commercial and investigational-stage products, participates in clinical and industry collaborations (such as infusion therapy advisory councils), and has pursued strategic transactions to expand its portfolio and market presence.
🔥 8 minutes ago
Inside Sales Specialist driving product awareness and utilization across healthcare accounts for CorMedix. Engaged virtually with healthcare professionals and decision-makers to improve patient access to therapies.
🇺🇸 United States – Remote
💵 $110k - $125k / year
💰 $123.2M Post-IPO Equity - Melinta Therapeutics on 2018-05
⏰ Full Time
🟡 Mid-level
🟠 Senior
⬇️ Inside Sales